Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2010, Article ID 621687, 8 pages
http://dx.doi.org/10.1155/2010/621687
Research Article

Comparison of the Pharmacological Effects of Paricalcitol and Doxercalciferol on the Factors Involved in Mineral Homeostasis

1Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612-7230, USA
2VidaGene, VDR Project, Chicago, IL 60612, USA
3Abbott Laboratories, Renal Care, Abbott Park, IL 60048, USA

Received 29 March 2009; Revised 6 August 2009; Accepted 11 November 2009

Academic Editor: Yan Chun Li

Copyright © 2010 J. Ruth Wu-Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Andress, “Vitamin D treatment in chronic kidney disease,” Seminars in Dialysis, vol. 18, no. 4, pp. 315–321, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. J. Brown, A. S. Dusso, and E. Slatopolsky, “Vitamin D analogues for secondary hyperparathyroidism,” Nephrology Dialysis Transplantation, vol. 17, supplement 10, pp. 10–19, 2002. View at Google Scholar · View at Scopus
  3. C. Carlberg, M. Quack, M. Herdick, Y. Bury, P. Polly, and A. Toell, “Central role of VDR conformations for understanding selective actions of vitamin D3 analogues,” Steroids, vol. 66, no. 3–5, pp. 213–221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Jones, S. A. Strugnell, and H. F. DeLuca, “Current understanding of the molecular actions of vitamin D,” Physiological Reviews, vol. 78, no. 4, pp. 1193–1231, 1998. View at Google Scholar · View at Scopus
  5. A. J. Brown, M. Berkoben, C. S. Ritter, and E. Slatopolsky, “Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells,” Endocrinology, vol. 130, no. 1, pp. 276–281, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Brandi, L. A. Fitzpatrick, H. G. Coon, and G. D. Aurbach, “Bovine parathyroid cells: cultures maintained for more than 140 population doublings,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 6, pp. 1709–1713, 1986. View at Google Scholar · View at Scopus
  7. E. Slatopolsky, M. Cozzolino, and J. L. Finch, “Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats,” Kidney International, vol. 62, no. 4, pp. 1277–1284, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Slatopolsky, M. Cozzolino, Y. Lu et al., “Efficacy of 19-nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia,” Kidney International, vol. 63, no. 6, pp. 2020–2027, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. H. E. Joist, S. N. Ahya, K. Giles, K. Norwood, E. Slatopolsky, and D. W. Coyne, “Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients,” Clinical Nephrology, vol. 65, no. 5, pp. 335–341, 2006. View at Google Scholar · View at Scopus
  10. A. J. Brown and D. W. Coyne, “Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism,” Treatments in Endocrinology, vol. 1, no. 5, pp. 313–327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Slatopolsky, J. Finch, C. Ritter, and F. Takahashi, “Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats,” American Journal of Kidney Diseases, vol. 32, no. 2, supplement 2, pp. S40–S47, 1998. View at Google Scholar · View at Scopus
  12. R. Karmali, S. Farrow, M. Hewison, S. Barker, and J. L. H. O'Riordan, “Effects of 1,25-dihydroxyvitamin D3 and cortisol on bovine and human parathyroid cells,” Journal of Endocrinology, vol. 123, no. 1, pp. 137–142, 1989. View at Google Scholar · View at Scopus
  13. M. G. Anderson, M. Nakane, X. Ruan, P. E. Kroeger, and J. R. Wu-Wong, “Expression of VDR and CYP24A1 mRNA in human tumors,” Cancer Chemotherapy and Pharmacology, vol. 57, no. 2, pp. 234–240, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus